Eads & Heald Wealth Management Charles River Laboratories International, Inc. Transaction History
Eads & Heald Wealth Management
- $214 Million
- Q1 2024
A detailed history of Eads & Heald Wealth Management transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Eads & Heald Wealth Management holds 1,951 shares of CRL stock, worth $389,536. This represents 0.25% of its overall portfolio holdings.
Number of Shares
1,951
Previous 2,073
5.89%
Holding current value
$389,536
Previous $490,000
7.96%
% of portfolio
0.25%
Previous 0.24%
Shares
7 transactions
Others Institutions Holding CRL
# of Institutions
728Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.21 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.03 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$418 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$375 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$302 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.2B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...